ArticleResearch square2020

Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform.

Flavia Chiuppesi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.